| Feasibility Study of a Multi-Component Intervention for Black Men Who Have Sex With Men (NCT00951249) | HIV Prevention Trials Network | 2009-07-01 |
| Evaluating the Pharmacokinetics of 400 mg Oral Dose of Raltegravir in HIV-Infected Pre-Menopausal Women (NCT00961272) | Kristine Patterson, MD | 2009-07-01 |
| Early Immune Responses to Vaccination - A Substudy to HVTN 205 (NCT00908323) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-07-01 |
| Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs) (NCT00951743) | Rapid Laboratories Inc. | 2009-07-01 |
| Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania (NCT00885287) | University of Copenhagen | 2009-07-01 |
| Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients (NCT00943540) | Radboud University Medical Center | 2009-07-01 |
| Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults (NCT00869518) | University of California, San Francisco | 2009-07-01 |
| Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV (NCT00926146) | University of California, Los Angeles | 2009-07-01 |
| To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection (NCT00959166) | Imperial College London | 2009-06-01 |
| Injecting Drug Use Community Intervention Trial (NCT01108614) | National Center for AIDS/STD Control and Prevention, China CDC | 2009-06-01 |
| Renal Function Assessment in HIV Patient (NCT00821847) | Assistance Publique - Hôpitaux de Paris | 2009-06-01 |
| Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya (NCT00931216) | University of California, San Francisco | 2009-06-01 |
| Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets (NCT00908011) | University of British Columbia | 2009-06-01 |
| A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children. (NCT00905489) | Boehringer Ingelheim | 2009-06-01 |
| Study of DDT and Loss of Clinically-Recognized Pregnancies in South Africa (NCT00878098) | National Institute of Environmental Health Sciences (NIEHS) | 2009-06-01 |
| Profile of HIV Seropositive Patients (NCT00981279) | Universidade Federal de Goias | 2009-06-01 |
| Linkage to Care - Part II (NCT00891644) | University of North Carolina, Chapel Hill | 2009-06-01 |
| Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules (NCT00937729) | University Hospital, Rouen | 2009-06-01 |
| Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects (NCT01047995) | St Stephens Aids Trust | 2009-06-01 |
| Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults (NCT00869700) | University of Cape Town | 2009-06-01 |
| Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice (NCT01375881) | Janssen-Cilag S.p.A. | 2009-06-01 |
| Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population (NCT00894257) | Centre Hospitalier Universitaire de Nice | 2009-05-25 |
| New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients (NCT00908544) | MUC Research GmbH | 2009-05-15 |
| Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men (NCT00865566) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-05-01 |
| Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA®) and Virologic Response to a CCR5 Antagonist in the Short Term (NCT01060618) | Asociacion para el Estudio de las Enfermedades Infecciosas | 2009-05-01 |
| Pilot Study of a Raltegravir Based NRTI Sparing Regimen (NCT00814879) | Yale University | 2009-05-01 |
| Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults (NCT00820118) | ANRS, Emerging Infectious Diseases | 2009-05-01 |
| Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS (NCT00887679) | Duke University | 2009-05-01 |
| Atazanavir and Lamivudine for Treatment Simplification (NCT00885482) | Catholic University of the Sacred Heart | 2009-05-01 |
| MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use (NCT01050465) | University of Missouri-Columbia | 2009-05-01 |
| Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV) (NCT01138267) | The HIV Netherlands Australia Thailand Research Collaboration | 2009-05-01 |
| Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients (NCT00973466) | Insel Gruppe AG, University Hospital Bern | 2009-05-01 |
| Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy (NCT00887653) | The Miriam Hospital | 2009-05-01 |
| Dating Violence and HIV Prevention in Girls: Adapting Mental Health Interventions (NCT01326195) | Rhode Island Hospital | 2009-05-01 |
| Combination Pain Therapy in HIV Neuropathy (NCT00863057) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-05-01 |
| FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women (NCT00625404) | FHI 360 | 2009-05-01 |
| Two Approaches to Routine HIV Testing in a Hospital Emergency Department (NCT01258582) | Massachusetts General Hospital | 2009-05-01 |
| Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia (NCT00753324) | University of North Carolina, Chapel Hill | 2009-05-01 |
| PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354. (NCT00908414) | Tibotec Pharmaceuticals, Ireland | 2009-05-01 |
| Exercise for Patients With HIV Infections (NCT00910936) | Charite University, Berlin, Germany | 2009-05-01 |
| Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection. (NCT00849160) | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | 2009-05-01 |
| Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy (NCT00851786) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-04-29 |
| A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women (NCT00855335) | Janssen Scientific Affairs, LLC | 2009-04-09 |
| Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease (NCT01001767) | University Hospitals Cleveland Medical Center | 2009-04-01 |
| A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy (NCT00870363) | University of California, Davis | 2009-04-01 |
| The Women's HIV SeroIncidence Study (ISIS) (NCT00995176) | HIV Prevention Trials Network | 2009-04-01 |
| Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients (NCT00893815) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2009-04-01 |
| Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection (NCT00879047) | University of California, San Francisco | 2009-04-01 |
| Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study (NCT00871234) | Indiana University | 2009-04-01 |
| Using Heavy Water to Study Cell Dynamics in Parkinson's Disease (NCT00990379) | Salena Killion | 2009-04-01 |
| Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults (NCT00869557) | Gilead Sciences | 2009-04-01 |
| A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers (NCT00851383) | International AIDS Vaccine Initiative | 2009-03-01 |
| Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals (NCT00497055) | San Francisco Department of Public Health | 2009-03-01 |
| IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents (NCT01061164) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2009-03-01 |
| Training Community Members to Deliver HIV Prevention Programs to Urban Youth (NCT00859144) | Icahn School of Medicine at Mount Sinai | 2009-03-01 |
| Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product (NCT00773708) | Germans Trias i Pujol Hospital | 2009-03-01 |
| Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients (NCT00872417) | Peking Union Medical College | 2009-03-01 |
| Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults (NCT00608569) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-03-01 |
| Buprenorphine/Raltegravir Pharmacokinetic Interaction Study (NCT00858962) | Yale University | 2009-03-01 |
| Chloroquine for Reducing Immune Activation in HIV- Infected Individuals (NCT00819390) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-03-01 |
| Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients (NCT00876733) | Boehringer Ingelheim | 2009-03-01 |
| Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection (NCT01084954) | George Washington University | 2009-03-01 |
| Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients (NCT00843661) | Ospedale di Circolo - Fondazione Macchi | 2009-03-01 |
| Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners (NCT01111721) | University of North Carolina, Chapel Hill | 2009-03-01 |
| Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs) (NCT00829114) | FHI 360 | 2009-03-01 |
| A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication (NCT00840762) | Ruth M. Rothstein CORE Center | 2009-03-01 |
| Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV (NCT00782808) | SEARCH Research Foundation | 2009-03-01 |
| Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection (NCT00859677) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2009-03-01 |
| Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response (NCT00772590) | Kirby Institute | 2009-03-01 |
| Raltegravir Activity In Lymphoid Tissues (NCT00863668) | University of Minnesota | 2009-03-01 |
| Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People (NCT00864916) | Indiana University | 2009-03-01 |
| Human Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CT (NCT00958815) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2009-03-01 |
| HIV Testing in the Emergency Department at Baystate Medical Center: A Pilot Program (NCT00987194) | Baystate Medical Center | 2009-03-01 |
| HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine (NCT00855413) | University of North Carolina, Chapel Hill | 2009-03-01 |
| Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults (NCT00695877) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-08 |
| Treatment De-Intensification and Residual HIV-1 in Youth (NCT00867854) | University of North Carolina, Chapel Hill | 2009-02-01 |
| Safety of Cotrimoxazole in HIV- and HAART-exposed Infants (NCT01086878) | Harvard School of Public Health (HSPH) | 2009-02-01 |
| Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans (NCT00792519) | Brown University | 2009-02-01 |
| HIV Prevention Program for African American Teen Males (NCT00849823) | Richard Crosby | 2009-02-01 |
| Sexually Transmitted Infections Among African American Women Who Have Sex With Women (NCT01043081) | University of Mississippi Medical Center | 2009-02-01 |
| Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women. (NCT00825929) | Radboud University Medical Center | 2009-02-01 |
| Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (NCT00848211) | Thymon, LLC | 2009-02-01 |
| Safety of Acidform Lubricant in HIV-Uninfected Women (NCT00850837) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-01 |
| Maraviroc Immune Recovery Study (NCT00875368) | S.F.L. van Lelyveld | 2009-02-01 |
| Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector (NCT00801697) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-01 |
| Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa (NCT00640887) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-02-01 |
| Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine (NCT00808002) | Germans Trias i Pujol Hospital | 2009-02-01 |
| The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study (NCT00824278) | National Institute of Mental Health (NIMH) | 2009-01-13 |
| Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients (NCT00677300) | Dallas VA Medical Center | 2009-01-01 |
| Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV (NCT00842634) | University of Pennsylvania | 2009-01-01 |
| Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients (NCT00762892) | The University of Texas Health Science Center, Houston | 2009-01-01 |
| Simplification From Protease Inhibitors to Raltegravir (NCT00941083) | Hospital Carlos III, Madrid | 2009-01-01 |
| Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men (NCT00856323) | Friends Research Institute, Inc. | 2009-01-01 |
| Observational Study on Patients With HIV/AIDS(OSPWH) (NCT04667026) | Guangzhou 8th People's Hospital | 2009-01-01 |
| Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center (NCT00870857) | University of Pittsburgh | 2009-01-01 |
| Immune Responses in Patients Treated With Raltegravir (NCT00785967) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2009-01-01 |
| Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa? (NCT00817713) | Swiss Tropical & Public Health Institute | 2009-01-01 |
| Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults (NCT00820846) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-01-01 |
| Pharmacotherapy for HIV Infected Patients With Alcohol Problems (NCT00854230) | VA Connecticut Healthcare System | 2009-01-01 |
| Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding (NCT00803543) | University of Alabama at Birmingham | 2009-01-01 |